Integrated Filing — IndAS



General information about company

Scrip Code 500875
NSE Symbol ITC
MSEI Symbol NOTLISTED
ISIN INE154A01025
Name of company ITC Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 02-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 02-11-2026   14:45:00
End date and time of board meeting 02-11-2026   18:05:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 30,57,840.00 60,10,170.00
Other income 50,736.00 1,16,307.00
Total income 31,08,576.00 61,26,477.00
2 Expenses
(a) Cost of materials consumed 7,72,901.00 14,71,116.00
(b) Purchases of stock-in-trade 1,66,659.00 4,53,254.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (18,069.00) (1,13,803.00)
(d) Employee benefit expense 1,88,652.00 3,76,353.00
(e) Finance costs 3,827.00 7,805.00
(f) Depreciation, depletion and amortisation expense 49,060.00 91,833.00
(f) Other Expenses
1 Excise Duty 10,30,977.00 20,71,870.00
2 Other Expenses 3,52,237.00 6,68,811.00
Total other expenses 13,83,214.00 27,40,681.00
Total expenses 25,46,244.00 50,27,239.00
3 Total profit before exceptional items and tax 5,62,332.00 10,99,238.00
4 Exceptional items (2,566.00) 38,022.00
5 Total profit before tax 5,59,766.00 11,37,260.00
6 Tax expense
7 Current tax 1,41,012.00 2,76,847.00
8 Deferred tax 5,517.00 4,888.00
9 Total tax expenses 1,46,529.00 2,81,735.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,13,237.00 8,55,525.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 9,696.00 18,287.00
16 Total profit (loss) for period 4,22,933.00 8,73,812.00
17 Other comprehensive income net of taxes (13,309.00) 23,262.00
18 Total Comprehensive Income for the period 4,09,624.00 8,97,074.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 4,16,840.00 8,56,253.00
Total profit or loss, attributable to non-controlling interests 6,093.00 17,559.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 4,03,573.00 8,79,557.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 6,051.00 17,517.00
21 Details of equity share capital
Paid-up equity share capital 1,25,305.00 1,25,305.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.32 6.83
Diluted earnings (loss) per share from continuing operations 3.32 6.83
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.32 6.83
Diluted earnings (loss) per share from continuing and discontinued operations 3.32 6.83
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. ‘Revenue from operations’ includes ‘Gross Revenue from sale of products and services’ and ‘Other operating revenue’. 2. ‘Purchase of stock-in-trade’ should be read as ‘Purchase of Stock-in-Trade and Biological Assets’. 3. ‘Changes in inventories of finished goods, work-in-progress and stock-in-trade’ should be read as ‘Changes in inventories of finished goods, Stock-in-Trade, work-in-progress, intermediates and Biological Assets’. 4. ‘Depreciation, depletion and amortisation expense’ should be read as ‘Depreciation and amortization expense’. NOTES TO STATEMENT OF UNAUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30TH SEPTEMBER, 2026 1. The unaudited Consolidated Financial Results, Segment Results, Balance Sheet and Statement of Cash Flows were reviewed by the Audit Committee, and approved by the Board of Directors of the Company at its meeting held on 2nd November, 2026. 2. The continuing significant brand building costs covering a range of personal care and branded packaged food products are reflected under 'Other expenses' stated above and in Segment Results under 'FMCG-Others'. 3. 10,48,850 Ordinary Shares of Re. 1/- each were issued and allotted under the Company's Employee Stock Option Schemes during the quarter ended 30th September, 2026. Consequently, the issued and paid-up Share Capital of the Company stands increased to Rs. 1253,05,17,081/- as on 30th September, 2026. 4. The Group on 1st August, 2026 completed acquisition of the pulp and paper business of Aditya Birla Real Estate Limited, operated under the name of 'Century Pulp and Paper', along with the assets, liabilities, contracts, employees etc., as a going concern on a slump sale basis, in accordance with the Business Transfer Agreement dated 31st March, 2025. The fair value of assets and liabilities of 'Century Pulp and Paper' have been provisionally determined and recorded in accordance with Ind AS 103 - 'Business Combinations'. Accordingly, the financial results of the Company and 'Paperboards, Paper & Packaging' segment include those of 'Century Pulp and Paper' from 1st August, 2026 and consequently are not comparable with previous periods. 5. Sproutlife Foods Private Limited ('Sproutlife') became a subsidiary of the Company with effect from 1st April, 2026, consequent to the Company acquiring the right to nominate majority of Directors on its Board. In accordance with Ind AS 103 - Business Combinations, the Group has re-measured its existing interest in Sproutlife at fair value. The fair values of assets and liabilities of Sproutlife have been provisionally determined and recorded in accordance with Ind AS 103 - Business Combinations and have been reflected in 'FMCG - Others' segment. The financial results of the Group and 'FMCG-Others' segment include those of Sproutlife with effect from 1st April, 2026. Accordingly, results of the quarter and six months ended 30th September, 2026 are not comparable with previous periods. The Company on 28th September, 2026 acquired additional 13,445 Equity Shares of Rs. 10/- each of Sproutlife, consequent to which Sproutlife became a wholly owned subsidiary of the Company with effect from the said date. Further, the Board of Directors of the Company at the meeting held today i.e. 2nd November, 2026 has approved, subject to necessary approvals, the Scheme of Amalgamation of Sproutlife Foods Private Limited, with the Company under Sections 230 and 232 of the Companies Act, 2013. 6. Exceptional Items for the six months ended 30th September, 2026 of Rs. 380.22 Crores represents : a) expenses of Rs. 25.66 crores during the quarter ended 30th September, 2026 incurred in relation to the acquisition of the pulp and paper business of Aditya Birla Real Estate Limited, operated under the name of 'Century Pulp and Paper' (Refer Note 4 above). b) gain of Rs. 405.88 crores during the quarter ended 30th June, 2026 on remeasurement of existing interest in Sproutlife at fair value in accordance with Ind AS 103 - Business Combinations (Refer Note 5 above). Exceptional Items for the quarter and six months ended 30th September, 2025 of Rs. 88.08 crores represent final settlement of the insurance claim towards leaf tobacco stocks, which were destroyed due to fire at a third party owned warehouse in an earlier year. 7. Consequent to expiry of the GST Compensation Cess, the Government of India increased GST and Central Excise duty on cigarettes with effect from 1st February, 2026. In accordance with Ind AS 115 - Revenue from Contracts with Customers and Schedule III to the Companies Act, 2013, GST and GST Compensation Cess are excluded from Gross Revenue from sale of products, whereas Excise duty is not excluded. Consequently, Gross Revenue from sale of products and services and Excise duty for the quarters ended 30th September, 2026, 30th June, 2026 and six months ended 30th September, 2026 reflect the impact of sharp increase in Excise duty and are not strictly comparable with those of the previous periods. 8. This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 20,01,038.00
Capital work-in-progress 1,92,426.00
Investment property 30,024.00
Goodwill 1,51,465.00
Other intangible assets 4,26,722.00
Intangible assets under development 12,124.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 5,15,029.00
Non-current financial assets
Non-current investments 7,47,513.00
Trade receivables, non-current 0.00
Loans, non-current 366.00
Other non-current financial assets
1 Other non-current financial assets 11,337.00
Total of other non-current financial assets 11,337.00
Total non-current financial assets 7,59,216.00
Deferred tax assets (net) 14,837.00
Other non-current assets
1 Right-of-use assets 55,253.00
2 Other non-current assets 1,29,144.00
3 Income Tax Assets (net) 5,802.00
Total of other non-current assets 1,90,199.00
Total non-current assets 42,93,080.00
2 Current assets
Inventories 22,97,537.00
Current financial asset
Current investments 17,50,981.00
Trade receivables, current 4,75,379.00
Cash and cash equivalents 83,462.00
Bank balance other than cash and cash equivalents 3,17,837.00
Loans, current 738.00
Other current financial assets
Total of other current financial assets 2,00,919.00
Total current financial assets 28,29,316.00
Current tax assets (net) 0.00
Other current assets
1 Biological assets other than bearer plants 28,352.00
2 Other current assets 1,87,267.00
Total of other current assets 2,15,619.00
Total current assets 53,42,472.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 96,35,552.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,25,305.00
Other equity 70,14,867.00
Total equity attributable to owners of parent 71,40,172.00
Non controlling interest 53,827.00
Total equity 71,93,999.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 6,000.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liabilities 17,027.00
2 Other financial liabilities 41,623.00
Total of other non-current financial liabilities 58,650.00
Total non-current financial liabilities 64,650.00
Provisions, non-current 47,225.00
Deferred tax liabilities (net) 3,18,552.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 4,332.00
Total of other non-current liabilities 4,332.00
Total non-current liabilities 4,34,759.00
Current liabilities
Current financial liabilities
Borrowings, current 18,293.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 36,588.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,91,675.00
Total Trade payable 6,28,263.00
Other current financial liabilities
1 Lease Liabilities 7,818.00
2 Other financial liabilities 2,17,649.00
Total of other current financial liabilities 2,25,467.00
Total current financial liabilities 8,72,023.00
Other current liabilities 9,02,609.00
1 Other current liabilities 9,02,609.00
Total of other current liabilities 9,02,609.00
Provisions, current 40,806.00
Current tax liabilities (Net) 1,91,356.00
Deferred government grants, Current 0.00
Total current liabilities 20,06,794.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 24,41,553.00
Total equity and liabilites 96,35,552.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 FMCG - Cigarettes 16,23,711.00 32,83,378.00
2 FMCG - Others 7,21,836.00 13,90,626.00
3 Agri Business 4,55,060.00 12,68,841.00
4 Paperboards, Paper & Packaging 3,01,745.00 5,32,772.00
5 Others 1,44,987.00 2,82,937.00
Total Segment Revenue 32,47,339.00 67,58,554.00
Less: Inter segment revenue 2,04,238.00 7,74,471.00
Revenue from operations 30,43,101.00 59,84,083.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 FMCG - Cigarettes 4,04,449.00 7,81,360.00
2 FMCG - Others 57,669.00 1,06,166.00
3 Agri Business 51,841.00 87,795.00
4 Paperboards, Paper & Packaging 27,332.00 49,013.00
5 Others 17,610.00 34,136.00
Total Profit before tax 5,58,901.00 10,58,470.00
i. Finance cost 3,827.00 7,805.00
ii. Other Unallocable Expenditure net off Unallocable income (14,388.00) (1,04,882.00)
Profit before tax 5,69,462.00 11,55,547.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 FMCG - Cigarettes 14,37,624.00 14,37,624.00
2 FMCG - Others 17,99,721.00 17,99,721.00
3 Agri Business 8,25,589.00 8,25,589.00
4 Paperboards, Paper & Packaging 14,26,565.00 14,26,565.00
5 Others 3,27,825.00 3,27,825.00
Total Segment Asset 58,17,324.00 58,17,324.00
Un-allocable Assets 38,18,228.00 38,18,228.00
Net Segment Asset 96,35,552.00 96,35,552.00
4 Segment Liabilities
Segment Liabilities
1 FMCG - Cigarettes 9,83,301.00 9,83,301.00
2 FMCG - Others 3,55,568.00 3,55,568.00
3 Agri Business 1,41,151.00 1,41,151.00
4 Paperboards, Paper & Packaging 2,30,219.00 2,30,219.00
5 Others 1,28,270.00 1,28,270.00
Total Segment Liabilities 18,38,509.00 18,38,509.00
Un-allocable Liabilities 6,03,044.00 6,03,044.00
Net Segment Liabilities 24,41,553.00 24,41,553.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) 1. ‘Revenue from operations’ should be read as ‘Gross Revenue from sale of products and services’. 2. ‘Other Unallocable Expenditure net off Unallocable income’ should be read as ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’. 3. In case of 3 months ended 30.09.2026, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (72.58) Crores, Exceptional Items* of Rs. 25.66 Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 96.96 Crores. 4. In case of 6 months ended 30.09.2026, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (485.73) Crores, Exceptional Items* of Rs. (380.22) Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 182.87 Crores. * Refer Note 6 to the Consolidated Financial Results. Note: As stock options and stock appreciation rights are granted to align the interests of employees with those of shareholders and also to attract and retain talent for the Group as a whole, the charge thereof do not form part of the segment performance reviewed by the Corporate Management Committee.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss (17,081.00) 29,611.00
Total Amount of items that will not be reclassified to profit and loss (17,081.00) 29,611.00
2 Income tax relating to items that will not be reclassified to profit or loss (2,138.00) 4,296.00
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit or loss 1,096.00 (847.00)
Total Amount of items that will be reclassified to profit and loss 1,096.00 (847.00)
4 Income tax relating to items that will be reclassified to profit or loss (538.00) 1,206.00
5 Total Other comprehensive income (13,309.00) 23,262.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 11,37,260.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 7,805.00
Adjustments for decrease (increase) in inventories (3,85,693.00)
Adjustments for decrease (increase) in trade receivables, current (68,896.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 4,01,672.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 91,833.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 3.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (136.00)
Adjustments for dividend income 1,514.00
Adjustments for interest income 55,379.00
Adjustments for share-based payments 6,159.00
Adjustments for fair value losses (gains) (93,998.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 10,465.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (87,679.00)
Net cash flows from (used in) operations 10,49,581.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,13,284.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 8,36,297.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 55,85,350.00
Other cash payments to acquire equity or debt instruments of other entities 47,15,384.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 2,448.00
Purchase of property, plant and equipment 1,08,598.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 266.00
Cash receipts from repayment of advances and loans made to other parties 672.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 12,807.00
Interest received 61,420.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (4,49,266.00)
Net cash flows from (used in) investing activities 3,89,183.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 1,995.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,897.00
Repayments of borrowings 2,03,340.00
Payments of lease liabilities 4,002.00
Dividends paid 10,02,620.00
Interest paid 6,554.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 3,895.00
Net cash flows from (used in) financing activities (12,03,729.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 21,751.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 21,751.00
Cash and cash equivalents cash flow statement at beginning of period 61,883.00
Cash and cash equivalents cash flow statement at end of period 83,634.00